3Imamura A, Takahashi R, Murakami R,et al. The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels [ J 1. Eur J Endocrinol,2008 ; 158 ( 2 ) : 189-95.
5Ceriello A, Davidson J, Hanefeld M, et al. Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update[ J]. Nutr Metab Cardiovasc Dis, 2006 ; 16 ( 7 ) :453-6.
1[1]Maseri A. Inflammation, atherosclerosis, and ischemic events-exploring the hidden side of the moon. New Engl J Med,1997,336:1014-1016.
2[2]Haidari M, Javadi E, Sadeghi B, et al. Evaluation of C-reactive protein, a sensitive marker of inflammation, as a risk factor for stable coronary artery disease. Clin Biochem, 2001,33:309-315.
3[3]Stern MP. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes, 1995,44:369-374.
4[4]Barzilay JI, Abraham Linn, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes, 2001,50:2384-2388.
6Iiyama K, Nagano M, Yo Y, et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Hypertension, 1996,132: 779-782.
7Yeh ET, Anderson HV, Pasceri V, et al. C-Reactive Protein linking inflammation to cardiovascular complications. Circulation, 2001, 104:974-975.
8Zouridakis EG, Schwartzman R, Garcia-Moll X, et al. Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart H, 2001, 22: 1578-1584.
9Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults of atherosclerosis. Lancet,1992, 34: 1111-1115.
10O' leafy DH, Polak JF, Kronmal RA, et al. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults.N Engl J Med, 1999, 340: 14-22.
